Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	11.81	53.47	47.82
Graham Fair Price	-4.90	12.00	12.62
PEG	17405.72	-3.18	0.02
Price/Book	10.92	5.88	5.30
Price/Cash Flow	2614.58	-1119.31	41.23
Prices/Earnings	15.74	23.41	20.23
Price/Sales	15.43	2.96	2.56
Price/FCF	2614.58	-1119.31	41.23
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.52	0.25	0.24
Operating Margin	1.24	0.04	0.04
ROA	-7.70	0.02	0.02
ROE	0.07	0.06	-4.16
ROIC	0.04	0.04	-6.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.12	-57.55
Dividends QOQ	< 0.005	0.09	8114.23
EBIT QOQ	0.17	-0.06	-66.43
EPS QOQ	11.12	-0.07	-99.34
FCF QOQ	3.32	-1.04	-68.69
Revenue QOQ	0.08	-0.07	-12.45
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	37.48	41.05	9.53
Days Sales Outstanding (DSO)	4.57	5.06	10.76
Inventory Turnover	2.40	2.19	-8.70
Debt/Capitalization	0.34	0.36	6.53
Quick Ratio	0.20	0.19	-4.78
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.39	10.09	-2.86
Cash	1.22	1.17	-4.48
Capex	-0.74	-0.58	21.01
Free Cash Flow	1.34	-0.05	-96.03
Revenue	21.49	20.06	-6.66
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.83	0.80	-3.49
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.96	5.52	11.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating